Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia
Epilepsia · 2025
DOI: 10.1111/epi.18351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Zichen Qiao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Receptors, GABA, Malformations of Cortical Development. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Beijing Hospitals Authority Clinical Medicine Development of special funding support.
Abstract (Originalsprache)
Objective
The identification of epileptic lesions is crucial for improving surgical outcomes. Nevertheless, substantial focal cortical dysplasia (FCD) may be invisible on magnetic resonance imaging (MRI). We aimed to characterize the expression pattern of 18‐kDa translocator protein (TSPO) in FCD and to evaluate the effectiveness of this inflammation‐reflective molecular imaging technique for detecting FCD.
Methods
Patients clinically diagnosed with FCD, based on clinical features, interictal electroencephalographic (EEG) findings, and MRI characteristics, underwent positron emission tomography (PET) imaging using 18 F‐DPA714 and 18 F‐fluorodeoxyglucose (FDG) tracers. TSPO‐PET activation patterns were qualitatively evaluated. Semiquantitative analysis using the Highlight Index (HI) was further performed to investigate its correlation with clinical characteristics. For patients who underwent stereo‐EEG (SEEG) monitoring, the site of high‐level TSPO‐PET activation was compared with the seizure onset zone identified by SEEG. For patients who underwent resection surgery, the relationship between TSPO‐PET uptake and histopathological findings was studied.
Results
Twenty‐four patients were enrolled. Three groups were identified: MRI‐positive with visible high‐level TSPO‐PET activation (six patients), MRI‐negative with visible high‐level TSPO‐PET activation (thirteen patients), and MRI‐positive with invisible low‐level TSPO‐PET activation (five patients). Regions of high‐level TSPO‐PET activation showed concordance with ictal discharges in five patients who underwent SEEG. Compared with FDG‐PET, TSPO‐PET exhibited a more prominent signal against the background ( p = .0158). HI was correlated with seizure frequency ( p = .0362) and the occurrence of focal to bilateral tonic–clonic seizures ( p = .0294), and shorter interval between the TSPO‐PET scan and the last seizure was associated with higher TSPO‐PET HI ( R = −.4323, p = .0349). Postoperative histopathological examination confirmed high‐level TSPO‐PET activation rates of 3/3 for FCD type IIb and 1/3 for FCD type IIa. Significance TSPO‐PET activation patterns offer clinical significance for improving surgical outcomes by enhancing FCD detection during presurgical evaluation. Also, our observations offer new insights into the histopathological basis for increased TSPO uptake in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Clinical Research Center of Epilepsy, Xuanwu Hospital, Capital Medical University, Beijing, China.
- National Center for Neurological Disorders, Beijing, China.
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China.
ORCID-Profile: Zichen Qiao, Yihe Wang, Yicong Lin, Tao Yu, Yuping Wang, Yueshan Piao, Jie Lu
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Beijing Hospitals Authority Clinical Medicine Development of special funding support
- The Medical and health technology development program in Shandong province
- Beijing Research Ward Excellence Program
- National Key Research and Development Program of China
Zitieren
APA
Qiao, Z., Yang, Y., Chen, Y., Guo, L., Xue, Q., Gao, L., Chen, J., Cui, B., Liu, J., Yang, H., Wang, X., Wang, Y., Zhang, H., Xu, C., Lin, Y., Yu, T., Wang, Y., Piao, Y., Lu, J., & Ren, L. (2025). Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia. Epilepsia. https://doi.org/10.1111/epi.18351
Vancouver
Qiao Z, Yang Y, Chen Y, Guo L, Xue Q, Gao L, et al. Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia. Epilepsia. 2025. doi:10.1111/epi.18351
BibTeX
@article{Qiao2025,
author = {Qiao, Zichen and Yang, Yingxue and Chen, Yuanhong and Guo, Linai and Xue, Qing and Gao, Lehong and Chen, Jia and Cui, Bixiao and Liu, Jinghui and Yang, Haoxun and Wang, Xueyuan and Wang, Yihe and Zhang, Huaqiang and Xu, Cuiping and Lin, Yicong and Yu, Tao and Wang, Yuping and Piao, Yueshan and Lu, Jie and Ren, Liankun},
title = {Emerging translocator protein–positron emission tomographic imaging improves detection of focal cortical dysplasia},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18351}
}
EUVIMED